Clinical Trial Update: A Multimodal Imaging Study of Dopamine in Early Psychosis [Phase 1]

View source ↗

Summary

Phase 1 multimodal imaging study exploring dopamine in individuals at clinical high risk for psychosis; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Clinical High Risk for Psychosis (CHR) | Phase 1 | Status: NOT_YET_RECRUITING